These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 421720)

  • 1. Patterns of cell survival following treatment with antitumor agents in vitro.
    Drewinko B; Roper PR; Barlogie B
    Eur J Cancer (1965); 1979 Jan; 15(1):93-9. PubMed ID: 421720
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell survival following treatment with antitumor drugs.
    Roper PR; Drewinko B
    Cancer Res; 1979 Apr; 39(4):1428-30. PubMed ID: 421227
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential sensitivities of human malignant lymphoma cell lines to anti-cancer drugs].
    Morikawa K; Harada T
    Rinsho Ketsueki; 1983 Apr; 24(4):355-62. PubMed ID: 6887536
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a human tumour cell line panel for screening of anti-tumour agents in vitro.
    Fricker SP; Buckley RG
    Biochem Soc Trans; 1989 Dec; 17(6):1049-50. PubMed ID: 2628072
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of the cytotoxic effects of some antineoplastic drugs on cultured T-lymphoma cells by microcalorimetry.
    Kimura T; Schön A; Wadsö I
    Cytobios; 1990; 63(252):7-13. PubMed ID: 2257759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activity of lysophosphatidylcholine analogues on human lymphoma Raji cells.
    Fleer EA; Kim DJ; Nagel GA; Eibl H; Unger C
    Onkologie; 1990 Aug; 13(4):295-300. PubMed ID: 2234783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
    Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
    Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro photosensitizing properties of rhodamine 123 on different human tumor cell lines.
    Melloni E; Dasdia T; Fava G; Rocca E; Zunino F; Marchesini R
    Photochem Photobiol; 1988 Sep; 48(3):311-4. PubMed ID: 3222341
    [No Abstract]   [Full Text] [Related]  

  • 9. Potentiation of antitumor drug action by centrophenoxine: specificity.
    Sladek NE
    J Pharmacol Exp Ther; 1977 May; 201(2):518-26. PubMed ID: 323465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and semisynthesis of novel fredericamycin A derivatives with an improved antitumor profile.
    Abel U; Simon W; Eckard P; Hansske FG
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3292-7. PubMed ID: 16621542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biotin deficiency stimulates survival pathways in human lymphoma cells exposed to antineoplastic drugs.
    Griffin JB; Zempleni J
    J Nutr Biochem; 2005 Feb; 16(2):96-103. PubMed ID: 15681168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
    Untch M; Sevin BU; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():311-3. PubMed ID: 7906979
    [No Abstract]   [Full Text] [Related]  

  • 13. Amifostine does not protect malignant lymphoma cell lines from the cytotoxic effects of various chemotherapeutics in vitro.
    Kuittinen O; Ruokolainen H; Turpeenniemi-Hujanen T
    Leuk Lymphoma; 2001 Jul; 42(3):507-10. PubMed ID: 11699416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of single or combined application of the antitumor agents on KB cells in culture (author's transl)].
    Hisatsune K
    Fukuoka Igaku Zasshi; 1974 Nov; 65(11):864-77. PubMed ID: 4477113
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-dependent survival and cell-cycle progression of cultured cells exposed to chemotherapeutic drugs.
    Drewinko B; Barlogie B
    Cancer Treat Rep; 1976 Dec; 60(12):1707-17. PubMed ID: 1026329
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of cytostatics and hyperthermia on RAJI human lymphoma cells.
    Istomin YP; Zhavrid EA; Sachivko NV; Alexandrova EN; Pocheshinsky PV
    Exp Oncol; 2011 Mar; 33(1):19-23. PubMed ID: 21423090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cis-diamminedichloroplatinum (II) on cultured human lymphoma cells and its therapeutic implications.
    Drewinko B; Brown BW; Gottlieb JA
    Cancer Res; 1973 Dec; 33(12):3091-5. PubMed ID: 4760525
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel molecular mechanisms of antitumor action of dichloroacetate against T cell lymphoma: Implication of altered glucose metabolism, pH homeostasis and cell survival regulation.
    Kumar A; Kant S; Singh SM
    Chem Biol Interact; 2012 Jul; 199(1):29-37. PubMed ID: 22705712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological features and in vitro chemosensitivity of a new model of human melanoma.
    Greco C; Zupi G
    Anticancer Res; 1987; 7(4B):839-44. PubMed ID: 3674770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of the synthetic retinoid ST1926 on primary effusion lymphoma in vitro and in vivo models.
    Karam L; Houshaymi B; Abdel-Samad R; Jaafar M; Halloum I; Pisano C; Neipel F; Darwiche N; Abou Merhi R
    Oncol Rep; 2018 Feb; 39(2):721-730. PubMed ID: 29207182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.